Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic ReviewStefano Salciccia, Alessandro Gentilucci, Gianna Mariotti et al.|International Journal of Molecular Sciences|2022Cited by 25
Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the LiteratureGiovanni Battista Di Pierro, Vittorio Canale, Stefano Salciccia et al.|Cancers|2023Cited by 20
How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of TherapyAlessandro Sciarra, Giulio Bevilacqua, Valerio Santarelli et al.|Cancers|2024Cited by 14
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic reviewStefano Salciccia, Alessandro Gentilucci, Marco Frisenda et al.|Asian journal of urology|2023Cited by 13
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate CancerStefano Salciccia, Alessandro Gentilucci, Marco Frisenda et al.|Current Oncology|2022Cited by 11